Fresenius Medical Care Narrows 2026 Outlook as China Exit Hits Q3
Bad Homburg – November 03, 2026 -- Fresenius Medical Care narrowed its 2026 operating income outlook to between flat and negative mid-single-digit growth after third-quarter reported operating income fell 19% to EUR 384 million. Reported net income dropped 42%, mainly because of EUR 108 million in one-time costs tied to the company's China strategy refinement.
The company's revenue outlook remains broadly flat. New CEO Shervin J. Korangy said the narrowed range reflects operating income in the first nine months and expected fourth-quarter headwinds, placing 2026 in the lower half of the previous range.